FairJourney Bio has announced the expansion of its portfolio with the launch of state-of-the-art cryo-electron microscopy (cryo-EM) services, supported through the company’s advanced laboratories in San Diego, CA.
This strategic addition strengthens FJBio’s position as a trusted partner for pharmaceutical and biotechnology companies worldwide by providing accessible, high-resolution structural insights that accelerate antibody discovery, selection and design.
By combining cutting-edge technology with FJBio’s team of expert scientists, the service offering ensures partners gain access to top-quality data and receive comprehensive guidance throughout the discovery and development process.
Benefitting from industry-leading, high-throughput cryo-EM capabilities, utilising two state-of-the-art ThermoFisher Titan Krios 5 systems, the cryo-EM services enable rapid and scalable analysis, with models delivered within two to three weeks from sample delivery.
The offering supports both intermediate- and high-resolution validation of proteins, protein-protein and protein-ligand complexes, producing high-quality and highly interpretable protein structures to inform confident decision-making.
Tailored specifically for antibody discovery, the cryo-EM services deliver value across the R&D value chain, supporting programmes from early evaluation through to advanced optimisation.
Dr Werner Lanthaler, CEO of FairJourney Bio, commented: "Cryo-EM enables unique and powerful insights into molecular structures and interactions at an atomic level."
"Adding structure-based information from real-world images is a paradigm shift that allows researchers to de-risk their R&D projects along the entire value chain."
"The improved resolution removes guesswork at critical junctures in the R&D process and thus serves to both accelerate discovery projects as well as improve their success rates."
"FJBio’s cryo-EM platform with a dedicated team of experts is unmatched in terms of speed, scale and quality.”
"With the addition of cryo-EM services, supported by our high-end San Diego labs, we can provide our partners with the structural precision and expert support needed to accelerate the development of next-generation therapies," added Dr Christopher Arthur, CSO, Structural Biology, FairJourney Bio.